Radioligand Therapy (RLT) Market Trends and Clinical Adoption
The Radioligand Therapy (RLT) Market is witnessing rapid adoption driven by increasing awareness of precision oncology and the benefits of targeted cancer therapies. Oncologists are increasingly recommending RLT for prostate cancer, neuroendocrine tumors, and metastatic cancers due to its ability to selectively target malignant cells while minimizing systemic toxicity. The Radioligand Therapy...
0 Reacties 0 aandelen 28 Views 0 voorbeeld
Lifesone https://lifesone.com